Stockscreener 앱 받기
1.09
4.39%
-0.05
시간 외 거래:
1.08
-0.01
-0.92%
전일 마감가:
$1.14
열려 있는:
$1.39
하루 거래량:
6.92M
Relative Volume:
12.27
시가총액:
$2.16M
수익:
$502.00K
순이익/손실:
$-8.86M
주가수익비율:
-0.1922
EPS:
-5.67
순현금흐름:
$-10.71M
1주 성능:
-73.38%
1개월 성능:
-75.11%
6개월 성능:
-87.89%
1년 성능:
-93.94%
1일 변동 폭
$1.05
$1.43
1주일 범위
$0.8008
$3.89
52주 변동 폭
$0.8008
$24.00
Helius Medical Technologies Inc Stock (HSDT) Company Profile
명칭
Helius Medical Technologies Inc
전화
215-944-6100
주소
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
HSDT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
1.09 | 2.16M | 502.00K | -8.86M | -10.71M | -5.67 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-24 | 개시 | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc 주식(HSDT)의 최신 뉴스
Helius Medical Technologies (HSDT) Offers New Public Shares and Warrants - GuruFocus
Helius Medical Secures Nasdaq Bid Price Compliance, Eyes Equity Requirement Deadline - MSN
Stocks Dive After Key Announcements From Helius, Mullen, And Cibus - Finimize
Top Midday Decliners - marketscreener.com
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
Helius Medical Technologies compliant with Nasdaq price requirement - Medical Buyer
Financial Survey: Heart Tronics (OTCMKTS:HRTT) and Helius Medical Technologies (NASDAQ:HSDT) - Defense World
Helius Medical Secures $9.1M Financing: Complex Warrant Structure Offers Unique Investment Opportunity - Stock Titan
Helius Medical Technologies Prices $9.1 Mln Public Offering - Nasdaq
Helius Medical Technologies Announces Pricing Of $9.1 Million Public Offering - marketscreener.com
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering - Toronto Star
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Helius Medical Technologies, Inc. To Contact The Firm - ACCESS Newswire
Helius Medical Technologies Achieves Nasdaq Bid Price Compliance - TipRanks
Helius Medical regains Nasdaq minimum bid price compliance - Investing.com
Helius Medical (HSDT) Achieves Nasdaq Bid Price Compliance | HSDT Stock News - GuruFocus
Helius Medical Technologies Receives Confirmation of Nasdaq Compliance for Minimum Bid Price Requirement - Nasdaq
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria - GlobeNewswire
Helius Medical Clears First Nasdaq Hurdle: What's Next for the Neurotech Company's Listing Status - Stock Titan
Helius Medical Technologies to Present Breakthrough PoNS Study Results at CMSC Annual Meeting - MSN
Helius Medical Technologies to Announce Q2 2024 Financial Results - MSN
Helius Medical Achieves Key Milestone with First PoNS System Sale to VA - MSN
Helius Medical Secures First Insurance Reimbursement for PoNS Device - MSN
Helius Medical Technologies (NASDAQ:HSDT) Stock Price Down 5.4% – Here’s Why - Defense World
HSDT: Helius Medical Offers 3.45 Million Shares in New Stock Sal - GuruFocus
Helius Medical files to sell 3.45M shares of common stock - TipRanks
Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Ionis Pharmaceuticals (IONS) and Maze Therapeutics, Inc. (MAZE) - The Globe and Mail
Helius Medical Technologies Secures Key Reimbursement Approval for PoNS Device - MSN
Helius Medical (HSDT) Highlights Promising PoNS Device Study for MS Treatment | HSDT Stock News - GuruFocus
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting - The Manila Times
Helius to Spotlight Study Confirming Improved Long-Term - GlobeNewswire
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS ... - nrtoday.com
Helius Medical Technologies Replaces Board Member - Medical Product Outsourcing
Helius Medical Technologies to Begin Brain Injury Device Trials in Canada - Medical Product Outsourcing
Analysts Are Bullish on Top Healthcare Stocks: Lineage Therap (LCTX), Tenon Medical, Inc. (TNON) - The Globe and Mail
United Healthcare covers PoNS Device for MS patients By Investing.com - Investing.com South Africa
HSDT Gains Reimbursement Approval for PoNS Device from Major Ins - GuruFocus
United Healthcare covers PoNS Device for MS patients - Investing.com Australia
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device - The Manila Times
Helius Medical Technologies, Inc. Announces Reimbursement - GlobeNewswire
HSDT FINAL SEPT. 9 DEADLINE, ROSEN, A TOP RANKED LAW FIRM, Reminds Helius Medical Technologies, Inc. Investors of Important Monday Deadline in Securities Class ActionHSDT - ACCESS Newswire
Helius Medical Technologies (HSDT) to Release Quarterly Earnings on Monday - Defense World
Helius Medical Technologies (HSDT) Expected to Announce Earnings on Monday - The AM Reporter
Newtown-Based Helius Medical Technologies Issues Reverse Stock Split - BUCKSCO.Today
Helius Medical Technologies announces 1-for-15 reverse stock split - MSN
HELIUS MEDICAL TECHNOLOGIES, INC. SEC 10-Q Report - TradingView
Helius Medical Technologies initiates 1-for-15 reverse stock split to meet Nasdaq requirements - The Business Journals
Helius Medical (HSDT) Initiates 1-for-15 Reverse Stock Split | H - GuruFocus
Helius Announces 1-for-15 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq
HSDT stock touches 52-week low at $0.26 amid sharp annual decline - Investing.com
Helius Medical Technologies Announces Reverse Stock Split - marketscreener.com
Helius Medical Technologies Inc (HSDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.56%
1.70%
자본화:
|
볼륨(24시간):